Linorma T3 5mcg Tablet contains Liothyronine sodium, a synthetic form of the thyroid hormone triiodothyronine (T3), used primarily in the management of hypothyroidism and certain cases of myxedema. Liothyronine acts by supplementing deficient endogenous thyroid hormone levels, thereby regulating metabolism, growth, and development. This medication is indicated for patients with hypothyroidism due to thyroid hormone deficiency, thyroidectomy, or radioactive iodine therapy, as well as for diagnostic purposes in thyroid function testing. Linorma T3 is rapidly absorbed from the gastrointestinal tract, with a quick onset of action, making it suitable for situations requiring prompt correction of hypothyroid symptoms. The dosage must be individualized based on patient response and serum thyroid hormone levels, with careful monitoring to avoid overtreatment, which can lead to symptoms of hyperthyroidism such as palpitations, nervousness, and weight loss. Contraindications include untreated thyrotoxicosis and acute myocardial infarction. Caution is advised in patients with cardiovascular disease, adrenal insufficiency, or diabetes mellitus. Regular monitoring of thyroid function tests is essential to ensure therapeutic efficacy and safety. Linorma T3 should be administered under medical supervision with attention to dose adjustments during pregnancy, lactation, and in pediatric or elderly populations.